Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
J Hepatol ; 54(4): 729-37, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21146245

ABSTRACT

BACKGROUND & AIMS: Molecular mechanisms underlying alcoholic liver disease (ALD) are still not fully understood. Activating transcription factor-4 (ATF4) is the master coordinator of the integrated stress response (ISR), an adaptive pathway triggered by multiple stressors. which can promote cell death and induce metabolic dysregulation if the stress is intense or prolonged. The aim of this study was to assess the effect of alcohol on the ISR signaling pathway in human liver cells and to define the role of cytochrome P450 2E1 (CYP2E1) in this response. METHODS: Primary cultured human hepatocytes and human HepG2 cells over-expressing CYP2E1 by adenoviral infection were exposed to ethanol (25-100mM) for 8-48h. RESULTS: Ethanol treatment of both liver cells up-regulated ATF4 as well as the pro-survival and the pro-apoptotic transcriptional program of the ISR. Indeed, in CYP2E1-expressing HepG2 cells exposed to ethanol, the expression of ISR target genes (HMOX-1, GCLC, AsnS, IGFBP-1, GADD34,CHOP, ATF3, CHAC1) was induced. Up-regulation of ATF4 and the ISR transcriptional program was decreased by addition of the anti-oxidant glutathione. Several mechanisms mediated ATF4 protein induction, including, at early times, the phosphorylation of eIF2α which controls ATF4 translation, and, at later times, increased mRNA level and increased stability of the protein. A decrease in cell survival was also observed. CONCLUSIONS: This study demonstrates that both CYP2E1 and ethanol induce ATF4 and the integrated stress response, a pathway which coordinates signals from multiple stresses, as well as established risk factors for ALD, and can display detrimental cellular effects upon prolonged activation.


Subject(s)
Activating Transcription Factor 4/biosynthesis , Cytochrome P-450 CYP2E1/metabolism , Ethanol/toxicity , Hepatocytes/drug effects , Hepatocytes/metabolism , Activating Transcription Factor 4/genetics , Cells, Cultured , Eukaryotic Initiation Factor-2/metabolism , Gene Expression/drug effects , Hep G2 Cells , Humans , Liver Diseases, Alcoholic/etiology , Liver Diseases, Alcoholic/genetics , Liver Diseases, Alcoholic/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Risk Factors , Signal Transduction/drug effects , Stress, Physiological/drug effects , Stress, Physiological/genetics , Stress, Physiological/physiology
2.
Diabetes ; 70(9): 2067-2080, 2021 09.
Article in English | MEDLINE | ID: mdl-34078628

ABSTRACT

Excess chronic contact between microbial motifs and intestinal immune cells is known to trigger a low-grade inflammation involved in many pathologies such as obesity and diabetes. The important skewing of intestinal adaptive immunity in the context of diet-induced obesity (DIO) is well described, but how dendritic cells (DCs) participate in these changes is still poorly documented. To address this question, we challenged transgenic mice with enhanced DC life span and immunogenicity (DChBcl-2 mice) with a high-fat diet. Those mice display resistance to DIO and metabolic alterations. The DIO-resistant phenotype is associated with healthier parameters of intestinal barrier function and lower intestinal inflammation. DChBcl-2 DIO-resistant mice demonstrate a particular increase in tolerogenic DC numbers and function, which is associated with strong intestinal IgA, T helper 17, and regulatory T-cell immune responses. Microbiota composition and function analyses reveal that the DChBcl-2 mice microbiota is characterized by lower immunogenicity and an enhanced butyrate production. Cohousing experiments and fecal microbial transplantations are sufficient to transfer the DIO resistance status to wild-type mice, demonstrating that maintenance of DCs' tolerogenic ability sustains a microbiota able to drive DIO resistance. The tolerogenic function of DCs is revealed as a new potent target in metabolic disease management.


Subject(s)
Dendritic Cells/metabolism , Gastrointestinal Microbiome/physiology , Inflammation/metabolism , Metabolic Diseases/metabolism , Obesity/metabolism , Animals , Dendritic Cells/pathology , Diet, High-Fat , Inflammation/pathology , Male , Metabolic Diseases/pathology , Mice , Mice, Transgenic , Obesity/pathology
3.
Biochimie ; 168: 17-27, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31672596

ABSTRACT

Hepatitis C virus (HCV) infection and alcohol abuse are leading causes of chronic liver disease and frequently coexist in patients. The unfolded protein response (UPR), a cellular stress response ranging along a spectrum from cytoprotection to apoptosis commitment, has emerged as a major contributor to human diseases including liver injuries. However, the literature contains conflicting reports as to whether HCV and ethanol activate the UPR and which UPR genes are involved. Here we have used primary human hepatocytes (PHH) to reassess this issue and address combined impacts. In this physiologically relevant model, either stressor activated a chronic complete UPR. However, the levels of UPR gene induction were only modest in the case of HCV infection. Moreover, when combined to the strong stressor thapsigargin, ethanol exacerbated the activation of pro-apoptotic genes whereas HCV tended to limit the induction of key UPR genes. The UPR resulting from HCV plus ethanol was comparable to that induced by ethanol alone with the notable exception of three pro-survival genes the expressions of which were selectively enhanced by HCV. Interestingly, HCV genome replication was maintained at similar levels in PHH exposed to ethanol. In conclusion, while both HCV and alcohol activate the hepatocellular UPR, only HCV manipulates UPR signalling in the direction of a cytoprotective response, which appears as a viral strategy to spare its own replication.


Subject(s)
Ethanol/toxicity , Hepatitis C, Chronic/metabolism , Hepatocytes/metabolism , Liver/metabolism , Unfolded Protein Response , Apoptosis , Cell Line , Hepacivirus/physiology , Hepatitis C, Chronic/pathology , Hepatocytes/pathology , Humans , Liver/pathology , Signal Transduction , Virus Replication
4.
Biochem Pharmacol ; 68(7): 1371-81, 2004 Oct 01.
Article in English | MEDLINE | ID: mdl-15345327

ABSTRACT

Cytochrome P450 2E1 (CYP2E1) gene expression is known to be induced by interleukin-4 (IL4) and repressed by inflammatory cytokines, such as interleukin-1beta3 (IL1beta3) in human hepatocytes. The mechanisms involved in these transcriptional regulations remain elusive. In order to study these mechanisms, various constructs of the human CYP2E1 promoter were prepared and transfected into the human HepG2 hepatoma cell line. Our findings revealed that an IL4-responsive region of 128bp (-671/-544) was required to mediate induction by IL4. IL1beta caused moderate but significant decrease of the promoter activity, which was abolished when the two cytokines were combined. The IL1beta inhibitory effect is mediated through a regulatory sequence independent of that of IL4. Furthermore, by using specific signaling pathway inhibitors, we demonstrated that IL4 activation required protein kinase C (PKC) activation. In addition, our results suggest that induction by IL4 was not dependent on a single binding site but rather on a complex region which includes putative binding sites for signal transducer and activator of transcription (STAT)6, activator protein (AP)-1, nuclear factor kappa-B (NFkappaB), nuclear factor of activated T cells (NFAT) and CCAAT enhancer binding protein (C/EBP). Electrophoretic mobility shift assays suggest that AP1 and NFAT transcription factors are able to bind to three sites in the IL4-responsive region.


Subject(s)
Cytochrome P-450 CYP2E1/genetics , Interleukin-4/pharmacology , Promoter Regions, Genetic/drug effects , Response Elements/drug effects , Base Sequence , Binding Sites , Cytochrome P-450 CYP2E1/metabolism , DNA/analysis , Dose-Response Relationship, Drug , Drug Combinations , Gene Expression/drug effects , Humans , Interleukin-1/pharmacology , Molecular Sequence Data , Nuclear Proteins/metabolism , Promoter Regions, Genetic/genetics , Response Elements/genetics , Signal Transduction/drug effects , Signal Transduction/physiology , Transcription Factors , Tumor Cells, Cultured
5.
Biochem Pharmacol ; 81(2): 304-13, 2011 Jan 15.
Article in English | MEDLINE | ID: mdl-20950586

ABSTRACT

TCDD (2,3,7,8-tetrachlorodibenzodioxin), a highly persistent environmental pollutant and a human carcinogen, is the ligand with the highest affinity for the Aryl Hydrocarbon Receptor (AhR) that induces via the AhR, xenobiotic metabolizing enzyme genes as well as several other genes. This pollutant elicits a variety of systemic toxic effects, which include cancer promotion and diverse cellular alterations that modify cell cycle progression and cell proliferation. Large-scale studies have shown that the expression of Son of Sevenless 1 (SOS1), the main mediator of Ras activation, is one of the targets of dioxin in human cultured cells. In this study, we investigated the regulation of the previously uncharacterized SOS1 gene promoter by the AhR and its ligands in the human hepatocarcinoma cell line, HepG2. We found that several environmental pollutants (AhR ligands) induce SOS1 gene expression by increasing its transcription. Chromatin immunoprecipitation experiments demonstrated that the AhR binds directly and activates the SOS1 gene promoter. We also showed that dioxin treatment leads to an activated Ras-GTP state, to ERK activation and to accelerated cellular proliferation. All these effects were mediated by SOS1 induction as shown by knock down experiments. Our data indicate that dioxin-induced cellular proliferation is mediated, at least partially, by SOS1 induction. Remarkably, our studies also suggest that SOS1 induction leads to functional effects similar to those elicited by the well-characterized oncogenic Ras mutations.


Subject(s)
Cell Proliferation/drug effects , Environmental Pollutants/toxicity , Polychlorinated Dibenzodioxins/toxicity , SOS1 Protein/metabolism , Dose-Response Relationship, Drug , Extracellular Signal-Regulated MAP Kinases/genetics , Extracellular Signal-Regulated MAP Kinases/metabolism , Hep G2 Cells , Hepatocytes/cytology , Hepatocytes/drug effects , Hepatocytes/physiology , Humans , Phosphorylation , Polychlorinated Dibenzodioxins/administration & dosage , Promoter Regions, Genetic , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering , Receptors, Aryl Hydrocarbon/metabolism , SOS1 Protein/genetics , ras Proteins/genetics , ras Proteins/metabolism
6.
Toxicol Sci ; 115(2): 501-12, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20299546

ABSTRACT

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an environmental pollutant that binds the aryl hydrocarbon receptor (AhR), a transcription factor that triggers various biological responses. In this study, we show that TCDD treatment counteracts the p53 activation (phosphorylation and acetylation) elicited by a genotoxic compound, etoposide, in the human hepatocarcinoma cell line HepG2 and we delineated the mechanisms of this interaction. Using small interfering RNA knockdown experiments, we found that the newly described metastasis marker, anterior gradient-2 (AGR2), is involved in this effect. Both AGR2 messenger RNA (mRNA) and protein levels were increased (sixfold and fourfold, respectively) by TCDD treatment, and this effect was mediated by the AhR receptor. The half-life of AGR2 mRNA was unchanged by TCDD treatment. Analysis of the promoter of the AGR2 gene revealed three putative xenobiotic-responsive elements (XREs) in the proximal 3.5-kb promoter. Transient transfection of HepG2 cells by the Gaussia luciferase reporter gene driven by various deleted and mutated fragments of the promoter indicated that only the most proximal XRE was active. Binding of the AhR to the endogenous AGR2 promoter was also triggered by TCDD treatment. These results suggest that AhR ligands such as TCDD might contribute to tumor progression by inhibiting p53 regulation (phosphorylation and acetylation) triggered by genotoxicants via the increased expression of the metastasis marker AGR2.


Subject(s)
Environmental Pollutants/toxicity , Hepatocytes/drug effects , Polychlorinated Dibenzodioxins/toxicity , Proteins/metabolism , Acetylation , Carcinoma, Hepatocellular , Cell Line, Tumor , Drug Antagonism , Drug Interactions , Gene Expression Regulation, Neoplastic/drug effects , Hepatocytes/metabolism , Humans , Liver Neoplasms , Mucoproteins , Oncogene Proteins , Phosphorylation , Proteins/genetics , RNA, Small Interfering/metabolism , Receptors, Aryl Hydrocarbon/genetics , Receptors, Aryl Hydrocarbon/metabolism , Transfection , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
7.
Toxicology ; 261(3): 126-35, 2009 Jul 10.
Article in English | MEDLINE | ID: mdl-19460412

ABSTRACT

Particulate matter (PM) is suspected to play a role in environmentally-induced pathologies. Due to its complex composition, the contribution of each PM components to PM-induced biological effects remains unclear. Four samples of Paris PM(2.5) having different polyaromatic hydrocarbons and metals contents were compared with each other and with their respective aqueous and organic extracts used alone or in combination. The four PM(2.5) samples similarly induced granulocyte macrophage-colony stimulating factor (GM-CSF) release, a pro-inflammatory cytokine, by human bronchial epithelial cells. It results from the activation of upstream signalling pathways and the modulation of the cellular redox state that is different according to PM(2.5) samples. The PM-aqueous extracts contained soluble metals involved in hydroxyl radical production in abiotic conditions. However they slightly contributed to the intracellular reactive oxygen species production and GM-CSF release by comparison with organic extracts. Organic compounds transactivated the xenobiotic responsive element (XRE) and antioxidant responsive element (ARE), leading to increased cytochrome P450 1A1 expression and NADPH-quinone oxydoreductase-1 expression respectively but to different extend according to PM samples underlying differences in their bioavailability. Our study underlines that chemical composition of particles per se is insufficient to predict cellular effects and that the interaction and the bioavailability of the various components were critical.


Subject(s)
Bronchi/drug effects , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Inflammation Mediators/metabolism , Particulate Matter/toxicity , Bronchi/immunology , Bronchi/metabolism , Cell Line , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP1A1/metabolism , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Epithelial Cells/immunology , Epithelial Cells/metabolism , Humans , Metals/analysis , NAD(P)H Dehydrogenase (Quinone)/genetics , NAD(P)H Dehydrogenase (Quinone)/metabolism , Paris , Particle Size , Particulate Matter/chemistry , Polycyclic Aromatic Hydrocarbons/analysis , RNA, Messenger/metabolism , Reactive Oxygen Species/metabolism , Seasons , Signal Transduction/drug effects , Time Factors , Transcription Factors/metabolism , Transcriptional Activation/drug effects , Up-Regulation
8.
Cancer Res ; 68(5): 1407-16, 2008 Mar 01.
Article in English | MEDLINE | ID: mdl-18316604

ABSTRACT

T-cadherin delineates endothelial, myoepithelial, and ductal epithelial cells in the normal mouse mammary gland, and becomes progressively restricted to the vasculature during mammary tumorigenesis. To test the function of T-cadherin in breast cancer, we inactivated the T-cadherin (Cdh13) gene in mice and evaluated tumor development and pathology after crossing the mutation into the mouse mammary tumor virus (MMTV)-polyoma virus middle T (PyV-mT) transgenic model. We report that T-cadherin deficiency limits mammary tumor vascularization and reduces tumor growth. Tumor transplantation experiments confirm the stromal role of T-cadherin in tumorigenesis. In comparison with wild-type MMTV-PyV-mT controls, T-cadherin-deficient tumors are pathologically advanced and metastasize to the lungs. T-cadherin is a suggested binding partner for high molecular weight forms of the circulating, fat-secreted hormone adiponectin. We discern adiponectin in association with the T-cadherin-positive vasculature in the normal and malignant mammary glands and report that this interaction is lost in the T-cadherin null condition. This work establishes a role for T-cadherin in promoting tumor angiogenesis and raises the possibility that vascular T-cadherin-adiponectin association may contribute to the molecular cross-talk between tumor cells and the stromal compartment in breast cancer.


Subject(s)
Adiponectin/biosynthesis , Cadherins/physiology , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Mammary Neoplasms, Animal/metabolism , Neovascularization, Pathologic , Adiponectin/metabolism , Animals , Cadherins/metabolism , Female , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neoplasm Metastasis , Neoplasm Transplantation , Platelet Endothelial Cell Adhesion Molecule-1/biosynthesis
9.
J Hepatol ; 47(5): 691-8, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17640761

ABSTRACT

BACKGROUND/AIMS: Insulin-like growth factor-binding protein-1 (IGFBP-1) modulates cell growth and metabolism in a variety of physiopathological conditions. The aim of this study was to determine the molecular mechanisms involved in IGFBP-1 upregulation by ethanol. METHODS: We studied IGFBP-1 regulation by ethanol at the protein, mRNA and gene promoter levels in the human hepatocarcinoma cell line, HepG2, which does not express significantly ethanol-metabolizing enzymes. RESULTS: Ethanol (35-150mM) induced the IGFBP-1 mRNA and protein up to 5-fold in a dose-dependent manner. A similar effect was observed using primary cultures of human hepatocytes. Various inhibitors of ethanol metabolism and the antioxidant N-acetylcysteine did not prevent ethanol effects. While ethanol did not modify the IGFBP-1 gene promoter activity, it elicited a 2- to 3-fold increase in IGFBP-1 mRNA half-life and this stabilization required the 5' and the 3' untranslated mRNA region. Ethanol triggered a rapid activation of c-Jun N-terminal Kinase (JNK) in HepG2 cells and IGFBP-1 induction was significantly decreased by a specific inhibitor of JNK. CONCLUSIONS: This study reveals a novel pathway of gene regulation by alcohol which involves the activation of JNK and the consequent mRNA stabilization.


Subject(s)
Ethanol/pharmacology , Hepatocytes/drug effects , Insulin-Like Growth Factor Binding Protein 1/genetics , JNK Mitogen-Activated Protein Kinases/drug effects , Liver/drug effects , RNA Stability/drug effects , Antioxidants/pharmacology , Carcinoma, Hepatocellular/metabolism , Cell Line, Tumor , Central Nervous System Depressants/pharmacology , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Enzyme Activation/genetics , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Hepatocytes/metabolism , Humans , Insulin-Like Growth Factor Binding Protein 1/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Liver/metabolism , Liver Neoplasms/metabolism , Promoter Regions, Genetic/drug effects , Promoter Regions, Genetic/genetics , RNA Stability/genetics , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Signal Transduction/drug effects , Signal Transduction/genetics , Up-Regulation/drug effects , Up-Regulation/genetics
10.
J Biol Chem ; 281(28): 19124-33, 2006 Jul 14.
Article in English | MEDLINE | ID: mdl-16687408

ABSTRACT

Endoplasmic reticulum (ER) stress is sensed by cells in different physiopathological conditions in which there is an accumulation of unfolded proteins in the ER. A coordinated adaptive program called the unfolded protein response is triggered and includes translation inhibition, transcriptional activation of a set of genes encoding mostly intracellular proteins, and ultimately apoptosis. Here we show that insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1), a secreted protein that modulates IGF bioavailability and has other IGF-independent effects, is potently induced during ER stress in human hepatocytes. Various ER stress-inducing agents were able to increase IGFBP-1 mRNA levels, as well as cellular and secreted IGFBP-1 protein up to 20-fold. A distal regulatory region of the human IGFBP-1 gene (-6682/-6384) containing an activating transcription factor 4 (ATF4) composite site was required for promoter activation upon ER stress. Mutation of the ATF4 composite site led to the loss of IGFBP-1 regulation. Electrophoretic mobility shift assay revealed an ER stress-inducible complex that was displaced by an ATF4 antibody. Knockdown of ATF4 expression using two specific small interfering RNAs impaired up-regulation of IGFBP-1 mRNA, which highlights the relevance of ATF4 in endogenous IGFBP-1 gene induction. In addition to intracellular proteins involved in secretory and metabolic pathways, we conclude that ER stress induces the synthesis of secreted proteins. Increased secretion of IGFBP-1 during hepatic ER stress may thus constitute a signal to modulate cell growth and metabolism and induce a systemic adaptive response.


Subject(s)
Activating Transcription Factor 4/physiology , Endoplasmic Reticulum/metabolism , Insulin-Like Growth Factor Binding Protein 1/genetics , Insulin-Like Growth Factor Binding Protein 1/metabolism , Promoter Regions, Genetic , Activating Transcription Factor 4/metabolism , Cell Line, Tumor , Cloning, Molecular , Hepatocytes/metabolism , Humans , Liver/pathology , Mutation , Protein Binding , RNA, Small Interfering/metabolism , Transfection
11.
Am J Physiol Lung Cell Mol Physiol ; 285(3): L671-9, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12730081

ABSTRACT

Diesel exhaust particles (DEP) induce a proinflammatory response in human bronchial epithelial cells (16HBE) characterized by the release of proinflammatory cytokines after activation of transduction pathways involving MAPK and the transcription factor NF-kappaB. Because cellular effects induced by DEP are prevented by antioxidants, they could be mediated by reactive oxygen species (ROS). Using fluorescent probes, we detected ROS production in bronchial and nasal epithelial cells exposed to native DEP, organic extracts of DEP (OE-DEP), or several polyaromatic hydrocarbons. Carbon black particles mimicking the inorganic part of DEP did not increase ROS production. DEP and OE-DEP also induced the expression of genes for phase I [cytochrome P-450 1A1 (CYP1A1)] and phase II [NADPH quinone oxidoreductase-1 (NQO-1)] xenobiotic metabolization enzymes, suggesting that DEP-adsorbed organic compounds become bioavailable, activate transcription, and are metabolized since the CYP1A1 enzymatic activity is increased. Because NQO-1 gene induction is reduced by antioxidants, it could be related to the ROS generated by DEP, most likely through the activation of the stress-sensitive Nrf2 transcription factor. Indeed, DEP induced the translocation of Nrf2 to the nucleus and increased protein nuclear binding to the antioxidant responsive element. In conclusion, we show that DEP-organic compounds generate an oxidative stress, activate the Nrf2 transcription factor, and increase the expression of genes for phase I and II metabolization enzymes.


Subject(s)
Reactive Oxygen Species/metabolism , Respiratory Mucosa/drug effects , Respiratory Mucosa/metabolism , Vehicle Emissions/toxicity , Bronchi/cytology , Cell Nucleus/metabolism , Cells, Cultured , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP1A1/metabolism , Cytoplasm/metabolism , DNA-Binding Proteins/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Humans , NAD(P)H Dehydrogenase (Quinone)/genetics , NAD(P)H Dehydrogenase (Quinone)/metabolism , NF-E2-Related Factor 2 , Oxidative Stress/drug effects , Respiratory Mucosa/cytology , Trans-Activators/metabolism , Transcriptional Activation
SELECTION OF CITATIONS
SEARCH DETAIL